Skip to content

Evaluating the Implementation of National Comprehensive Cancer Network (NCCN) Genetic Risk Screening Criteria for Hereditary Breast Cancer in Thai Patients.

Evaluating the Implementation of National Comprehensive Cancer Network (NCCN) Genetic Risk Screening Criteria for Hereditary Breast Cancer in Thai Patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20251226002
Enrollment
20
Registered
2025-12-26
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast cancer Breast cancer Genetic risk assessment Cancer genetic screening Hereditary breast cancer Genetic screening Genetic risk assessment BRCA mutation National Comprehensive Cancer Network NCCN criteria Implementation research Mixed methods study Thailand

Interventions

This group consists of healthcare professionals involved in breast cancer care and genetic risk assessment including physicians nurses and genetic counselors. Participants will take part in qualitativ
Health Services Research
Healthcare professionals

Sponsors

Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria * 1.Adult Thai patients diagnosed with breast cancer who received care at the study site during the study period. 2. Patients with available medical records sufficient for assessment using the NCCN genetic risk screening criteria. 3.Healthcare professionals involved in breast cancer care and genetic risk assessment. 4.Healthcare professionals who are eligible and willing to participate in the qualitative interview component of the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria * 1. Patients with incomplete or missing medical records that prevent assessment using the NCCN genetic risk screening criteria. 2. Patients whose clinical data are unavailable or insufficient for retrospective review. 3. Patients who declined genetic evaluation or whose medical records could not be accessed for the quantitative component. 4. Healthcare professionals who are not directly involved in breast cancer care or genetic risk assessment. Healthcare professionals who are unwilling to participate in the qualitative interview process.

Design outcomes

Primary

MeasureTime frame
Perceptions of NCCN criteria implementation During study period after ethics approval In depth semi structured interviews with healthcare professionals analyzed using qualitative content analysis,Barriers to implementation of genetic risk screening During study period after ethics approval In depth semi structured interviews with healthcare professionals analyzed using qualitative content analysis

Secondary

MeasureTime frame
Facilitators of implementation of genetic risk screening During study period after ethics approval In depth semi structured interviews with healthcare professionals analyzed using qualitative content analysis,Proportion of patients screened for genetic risk During retrospective study period Review of medical records to determine the number and proportion of breast cancer patients assessed using the NCCN genetic risk screening criteria,Proportion of patients referred for genetic testing During retrospective study period Review of medical records to determine the number and proportion of breast cancer patients referred for genetic testing based on NCCN genetic risk screening criteria

Countries

Thailand

Contacts

Public ContactChayaluck Siripukdeekan

Mahidol University

chayaluck.tom@gmail.com0626369959

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026